Gilead Gilead aims to challenge GSK's HIV drug Tivicay But GSK hit back with plans for two-drug regimen.
Views & Analysis Exclusive: Brexit likely to cause long-term damage to UK pha... Exclusive survey finds concerns about future of UK pharma industry
News GSK settles US bribery probe for $20m Actions of Chinese subsidiaries violated US bribery laws, says SEC.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
